DNA vaccines: A ray of hope

Critical Reviews in Biochemistry and Molecular Biology

Volumn 34, Issue 1, 1999, Pages 1-24

  Tuteja, Renu ^a  

^a International Centre for Genetic Engineering and Biotechnlogy   (India)

Author keywords

Antibodies; B lymphocytes; Cytotoxic T lymphocytes; Disease; Immunization; Vaccine

Indexed keywords

BCG VACCINE; BUPIVACAINE; CANCER VACCINE; CARDIOTOXIN; COMPLEMENTARY DNA; COXSACKIE VIRUS B3 VACCINE; CYTOKINE; DNA VACCINE; DRUG CARRIER; HEPATITIS B VACCINE; HEPATITIS C VACCINE; HERPES VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INFLUENZA VACCINE; MALARIA VACCINE; PLASMID DNA; RABIES VACCINE; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; B LYMPHOCYTE; CANCER CONTROL; CYTOTOXIC T LYMPHOCYTE; DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG STABILITY; GENE GUN; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNIZATION; IMMUNOMODULATION; INFECTION CONTROL; INFLUENZA; INTRADERMAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALARIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABIES; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION; TUBERCULOSIS; VACCINE PRODUCTION; VIRUS INFECTION; VIRUS MYOCARDITIS;

EID: 0033030960     PISSN: 10409238     EISSN: None     Source Type: Journal    
DOI: 10.1080/10409239991209165     Document Type: Review

References (103)

1. Anderson, G., Urbano, O., Fedorka-Cray, P., Newell, A., Nunberg J., and Doyle, M. 1987. Interleukin-2 and protective immunity in Haemophilus pleuropneumoniae: preliminary studies. Vaccines, Cold Spring Harbor, 22-25.
2. Andre, S., Seed, B., Eberle, J., Schraut, W., Bultmann, A., and Haas, J. 1998. Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage. J. Virol. 72: 1497-1503.
3. Bagarazzi, M. L., Boyer, J. D., Ugen, K. E., Javadian, M. A., Chattergoon, M., Shah, A., Bennett, M., Ciccarelli, R., Carrano, R., Coney, L., and Weiner, D. B. 1998. Safety and immunogenecity of HIV-1 DNA constructs in chimpanzees. Vaccine 16: 1836-1841.
4. Barouch, D., Santra, H. S., Steenbeke, T. D., Zheng, X. X., Perry, H. C., Davies, M. E., Freed, D. C., Craiu, A., Strom, T. B., Shiver, J. W., and Letvin, N. L. 1998. Augementation and suppression of immune responses to an HIV-1 DNA vaccine by plasmid cytokine/Ig administration. J. Immunol. 161: 1875-1882.
5. Becker, S. I., Wang, R., Hedstrom, R. C., Aguiar, J. C., Jones, T. R., Hoffman, S. L., and Gardner, M. J. 1998. Protection of mice against Plasmodium yoelii sporozoite challenge with P. yoelii merozoite surface protein 1 DNA vaccines. Infect. Immun. 66: 3457-3461.
6. Bohm, W., Mertens, T., Sehirmbeck, R., and Reimann, J. 1998 Routes of plasmid DNA vaccination that prime murine humoral and cellular immune responses. Vaccine 16: 949-954.
7. Borgne, S. L., Mancini, M., Grand, R. L., Schleef, M., Dormant, D., Tiollais, P., Riviere Y., and Michel, M. L. 1998. In vivo induction of specific cytotoxic T lymphocytes in mice and rhesus macaques immunized with DNA vector encoding an HIV epitope fused with hepatitis B surface antigen. Virology 240: 304-315.
8. Boshart, M., Weber, F., Jahn, G., Dorsch Hasler, K., Fleckenstein, B., and Schaffner, W. 1985. A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 41: 521-530.
9. Boyer, J. D., Chattergoon, M. A., Ugen, K.E., Shah, A., Bennett, M., Chohen, A., Nyland, S., Lacy, K. E., Bagarazzi, M. L., Higgins, T. J., Baine, Y., Ciccarelli, R. B., Ginsberg, R. S., MacGregor, R. R., and Weiner, D. B. 1999. Enhancement of cellular immune response in HIV-1 seropositive individuals: a DNA-based trial. Clin. Immunol. 90: 100-107.
10. Boyer, J. D., Ugen, K. E., Wang, B., Agadjanyan, M., Gilbert, L., Bagarazzi, M. L., Chattergoon, M., Frost, P., Javadian, A., Williams, W. V., Refaeli, Y., Ciccarelli, R. B., McCallus, D., Coney L., and Weiner, D. B. 1997. Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. Nat. Med. 3: 526-532.
11. Calarota, S., Bratt, G., Nordlund, S., Hinkula, J., Leandersson, A. C., Sandstrom, E., and Wahren, B. 1998. Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients. Lancet 351: 1320-1325
12. Chapman, B. S., Thayer, R. M., Vincent, K. A., and Haigwood, N. L. 1991. Effect of intron A from human cytomegalovirus immediate - early gene on heterologous expression in mammalian cells. Nucl. Acids Res. 19: 3979-3986.
13. Chow, Y. H., Chiang, B.-L., Lee, Y. L., Chi, W.-K., Lin, W.-C., Chen, Y.-T., and Tao, M. H. 1998. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes. J. Immunol. 160: 1320-1329
14. Chow, Y.-H., Huang, W.-L., Chi, W.-K., Chu ,Y.-D., and Tao, M. H. 1997. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2. J. Virol. 71: 169-178.
15. Davis, H. L. 1997. Plamid DNA expression systems for the purpose of immunization . Curr. Opin. Biotech. 8: 635-640.
16. Davis, H. L., Mancini, M., Michel, M.-L., and Whalen, R. G. 1996a. DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost. Vaccine 14: 910-915.
17. Davis, H. L., McCluskie, M. J., Gerin, J. L., and Purcell, R. H. 1996b. DNA vaccine for hepatitis B: Evidence for immunogenicity in chimpanzees and comparision with other vaccines. Proc. Natl. Acad. Sci. U.S.A. 93: 7213-7218.
18. Davis, H. L., Michel, M-L., and Whalen, R. G. 1993. DNA based immunization for hepatitis B induces continuous secretion of antigen and high levels of circulating antibody. Human Mol. Genet. 2: 1847-1851.
19. Davis, H. L., Weeranata, R., Waldschmidt, T. J., Tygrett, L., Schorr, J., and Kreig, A. M. 1998. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J. Immunol. 160: 870-876.
20. Davis, H. L., Whalen, R. G., and Demeneix, B. A. 1993. Direct gene transfer into skeletal muscle in vivo: factors affecting efficiency of transfer and stability of expression. Hum. Gene Ther. 4: 151-159
21. Dixon, B. 1995. The Third Vaccine Revolution. Biotechnology 13: 420.
22. Encke, J., zu Putlith, J., Geissler, M., and Wands, J. R. 1998. Genetic immunization generates cellular and humoral immune responses against the nonstructural proteins of the hepatitis C virus in a murine model. J. Immunol. 161: 4917-4923.
23. Fomsgaard, A., Nielson, H. V., Bryder, K., Nielson, C., Machuca, R., Brunn, L., Hansen, J., and Buus, S. 1998. Improved humoral and cellular immune responses against the gp120 V3 loop of HTV 1 following genetic immunization with a chimeric DNA vaccine encoding the V3 inserted into the hepatitis B surface antigen. Scand. J. Immunol. 47: 289-295.
24. Forg, P., von Hoegen, P., Dalemans, W., and Schirrmacher, V. 1998 Superiority of the ear pinna over muscle tissue as site for DNA vaccination. Gene Ther. 5: 789-797.
25. Fynan, E. F., Webster, R. G., Fuller, D. H., Haynes, J. R., Santoro, J. C., and Robinson, H. L. 1993. DNA vaccines: protective immunization by parenteral, mucosal and gene gun inoculation. Proc. Natl. Acad. Sci. U.S.A. 90: 11478-11482.
26. Geissler, M., Tokushige, K., Wakita, T., Zurawski, V. R., Jr., and Wands, J. R. 1998. Differential cellular and humoral immune responses to HCV core and HBV envelope proteins after genetic immunizations using chimeric constructs. Vaccine 16: 857-867.
27. Goebels, N., Michaelis, D., Wekerle, M., and Hohfield, R. 1992. Human myoblasts as antigen-presenting cells. J. Immunol. 149: 661-667.
28. German, C. M., Merlino, G. T., Willingham, M. C., Pastan, I., and Howard, B. H. 1982. The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection. Proc. Natl. Acad. Sci.. U.S.A. 79: 6777-6781.
29. Gramzinski, R. A., Millan, C. L., Obaldia, N., Hoffman, S. L., and Davis, H. L. 1998. Immune response to a hepatitis B DNA vaccine in Aotus monkeys: a comparison of vaccine formulation, route and method of administration. Mol. Med. 4: 109-118
30. Hamajima, K., Sasaki, S., Fukushima, J., Kaneko, T., Xin, K. Q., Kudoh, I., and Okuda, K. 1998. Intranasal administration of HIV-DNA vaccine formulated with a polymer, carboxymethylcellulose, augments mucosal antibody production and cell-mediated immune response. Clin. Immunol. Immunopathol. 88: 205-210.
31. Henke, A., Wagner, E., Whitton, J. L., Zell, R., and Stelzner, A. 1998. Protection of mice against lethal Coxsackievirus B3 infection by using DNA immunization. J. Virol. 72: 8327-8331.
32. Hohfield, R. and Engel, A. G. 1994. The immunobiology of muscle. Immunol. Today 15: 269-274.
33. Hoshino, T., Jiang, Y. Z., Dunn, D., Paul, D., Qazilbash, M., Cowan, K., Wang, J., Barrett, J., and Liu, J. 1998. Transfection of interleukin-12 cDNAs into tumor cells induces cytotoxic immune responses against native tumor: implications for tumor vaccination. Cancer Gene Ther. 5: 150-157.
34. Huygen, K., J., Content, O., Denis, D. L., Montgomery, A. M., Yawman, R. R., Deck, C. M., Dewitt, I. M., Orme, S., Baldwin, C., Dsouza, A., Drowart, E., Lozes, P., Vandenbussche, J. P., Vooren, V., Liu, M. A., and Ulmer, J. B. 1996. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat. Med. 2: 893-898.
35. Inchauspe, G., Major, M. E., Nakano, I., Vivitski, L., Maisonnas, M., and Trepo, C. 1998. Immune responses against hepatitis C virus structural proteins following genetic immunization. Dev. Biol. Stand. 92: 163-168.
36. Inchauspe, G., Vitvitski, L., Major, M. E., Jung, G., Spengler, U., Maisonnas, M., and Trepo, C. 1997. Plasmid DNA expressing a secreted or a nonsecreted form of hepatitis C virus nucleocapsid: comparative studies of antibody and T-helper responses following genetic immunization. DNA Cell Biol. 16: 185-195.
37. Ishii, N., Fukushima, J., Kaneko, T., Okada, E., Tani, K., Tanaka, S. I., Hamajima, K., Xin, K. Q., Kawamoto, S., Koff., W., Nishioka, K., Yasuda, T., and Okuda, K. 1997. Cationic liposomes are a strong adjuvant for a DNA vaccine of human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses 13: 1421-1428.
38. Iwasaki, A. and Barber, B. H. 1998. Induction by DNA immunization of a protective antitumor cytotoxic T lymphocyte response against a minimal-epitope-expressing tumor. Cancer Immunol. Immunother. 45: 273-279.
39. Kandolf, R. and Hofschneider, P. H. 1989. Viral heart disease. Springer Semin. Immunopathol. 11: 1-13.
40. Kang, Y., Calvo, P. A., Daly, T. M., and Long, C. A. 1998. Comparison of humoral immune responses elicited by DNA and protein vaccines based on merozoite surface protein-1 from Plasmodium yoelii, a rodent malaria parasite. J. Immunol. 161: 4211-4219.
41. Kim, J. J., Bagarazzi, M. L., Trivedi, N., Hu, Y., Kazahaya, K., Wilson, D. M., Ciccarelli, R., Chattergoon, M. A., Dang, K., Mahalingam, S., Chalian, A. A., Agadjanyan, M. G., Boyer, J. D., Wang, B., and Weiner, D. B. 1997. Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes. Nature Biotech. 15: 641-646.
42. Kim, J. J., Nottingham, L. K., Wilson, D. M., Bagarazzi, M. L., Tsai, A., Morrison, L. D., Javadian, A., Chalian, A. A., Agadjanyan, M. G., and Weiner, D. B. 1998a. Engineering DNA vaccines via co-delivery of co-stimulatory molecule genes. Vaccine 16: 1828-1835.
43. Kim, J. J., Trivedi, N. N., Nottingham, L. K., Morrison, L., Tsai, A., Hu, Y., Mahalingam, S., Dang, K., Ahn, L., Doyle, N. K. Agadjanyan, M. G., and Weiner, D. B. 1998b. Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens. Eur. J. Immunol. 28: 1089-1103.
44. Klinman, D. M., Yamshchikov, G., and Ishigatsubo, Y. 1997. Contribution of CpG motifs to the immunogenicity of DNA vaccines. J. Immunol. 158: 3635-3639.
45. Klinman, D. M., Yi, A. K., Beaucage, S. L., Conover, J., and Krieg, A. M. 1996. CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12 and interferon gamma. Proc. Natl. Acad. Sci. U.S.A. 93: 2879-2883.
46. Kreig, A.M., Yi, A. K., Maison, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., and Klinman, D. M. 1995. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374: 546-549.
47. Lagging, L. M., Meyer, K., Hoft, D., Houghton, M., Belshe, R. B., and Ray, R. 1995. Immune responses to plasmid DNA encoding the hepatitis C virus core protein. J. Virol. 69: 5859-5863.
48. Lee, S.W., Cho, J. H., Lee, K. J., and Sung, Y. C. 1998b Hepatitis C virus envelope DNA based immunization elicits humoral and cellular immune responses. Mol. Cells 8: 444-451.
49. Lee, S.W., Cho, J.H., and Sung, Y.C. 1998a. Optimal induction of hepatitis C virus envelope-specific immunity by bicistronic plasmid DNA inoculation with the granulocyte - macrophage colony stimulating factor gene. J. Virol. 72: 8430-8436.
50. Leitner, W. W., Seguin, M. C., Ballou, W. R., Seitz, J. P., Sehultz, A. M., Sheety, M. J., and Lyon, J. A. 1997. Immune responses induced by intramuscular or gene gun injection of protective deoxyribonucleic acid vaccines that express the circumsporozoite protein from Plasmodium berghei malaria parasites. J. Immunol. 159: 6112-6119.
51. Lekutis, C., Shier, J. W., Liu M. A., and Letvin, N. L. 1997. HIV-1 env DNA vaccine administered to rhesus monkeys elicits MHC class II-restricted CD4 T helper cells that secrete IFN-g and TNF-a. J. Immunol. 158: 4471-4477.
52. Linsley, P. S., Clark, E. A., and Ledbetter, J. A. 1990. The T-cell antigen, CD28-mediated adhesion with B cells by interacting with activation antigen B7/BB-1. Proc. Natl. Acad. Sci. U.S.A. 87: 5031-5035.
53. Lodmell, D. L., Ray, N. B., Parnell, M. J., Ewalt, L. C., Hanlon, C. A., Shaddock, J. H., Sanderlin, D. S., and Rupprecht, C. E. 1998. DNA immunization protects nonhuman primates against rabies virus. Nat. Med. 8: 949-952.
54. MacGregor, R. R., Boyer, J. D., Ugen, K. E., Lacy, K. E., Gluckman, S. J., Bagarazzi, M. L., Chattergoon, M. A., Baine, Y., Higgins, T. J., Ciccarelli, R. B., Coney, L. R., Ginsberg, R. S., and Weiner, D. B. 1998. First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response. J. Infect. Dis. 178: 92-100.
55. Major, M. E., Vitvitski, L., Mink, M. A., Schleff, M., Whalen, R. G., Trepo, C., and Inchauspe, G. 1995. DNA-based immunization with chimeric vectors for the induction of immune responses against the hepatitis C virus nucleocapsid. J. Virol. 69: 5798-5805.
56. Mancini, M., Hadchouel, M., Davis, H. L., Whalen, R. G., Tiollais, P., and Michel, M. L. 1996. DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state. Proc. Natl. Acad. Sci. U.S.A. 93: 12496-12501.
57. Manickan, E., Rouse, R. J. D., Yu, Z., Wire, W. S., and Rouse, B. T. 1995. Genetic immunization against herpes simplex virus: protection is mediated by CD4+ T lymphocytes. J. Immunol. 155: 259-265.
58. Manthorpe, M., Cornefert-Jensen, F., Hartikka, J., Felgner, J., Rundell, A., Margalith, M., and Dwarki, V. J. 1993. Gene therapy by intramuscular injection of plasmid DNA: studies on firefly luciferase gene expression in mice. Hum. Gene Ther. 4: 419-431.
59. Maupas, P., Goudean, A., Coursaget, P., and Drucker, J. 1976 Immunization against hepatitis B in man. Lancet 1: 1367-1370.
60. Mendoza, R. B., Cantwell, M. J., and Kipps, T. J. 1997. Immunostimulatory effects of a plasmid expressing CD40 ligand (CD154) on gene immunization. J. Immunol. 159: 5777-5781.
61. Michaelis, D., Goebels, N., and Hohfield, R. 1993. Constitutive and cytokine-induced expression of human leukocyte antigens and cell adhesion molecules by human myo-tubes. Am. J. Pathol. 143: 1142-1149.
62. Michel, M.-L., Davis, H. L., Schleef, M., Mancini, M., Tiollais, P., and Whalen, R. G. 1995. DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans. Proc. Natl. Acad. Sci. U.S.A. 92: 5307-5311.
63. Michel, M. L., Pontisso, P., Sobezak, E., Malpiece, Y., Streeck, R. E., and Tiollais, P. 1984. Synthesis in animal cells of hepatitis B surface antigen particles carrying a receptor for polymerized human serum albumin. Proc. Natl. Acad. Sci. U.S.A. 81: 7708-7712.
64. Moldoveanu, Z., Love-Homan, L., Huang, W. Q., and Kreig, A. M. 1998. CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus. Vaccine 16: 1216-1224.
65. Mor, G., Klinman, D. M., Shapiro, S., Hagiwara, E., Sedegah, M., Norman, J. A., Hoffman, S. L., and Steinberg, A. D. 1995. Complexity of the cytokine and antibody response elicited by immunizing mice with Plasmodium yoelii circumsporozoite protein plasmid DNA. J. Immunol. 155: 2039-2046.
66. Moreau, P., Hen, R., Wasylyk, B., Everett, R., Gaub, M. P., and Chambon, P. 1981. The SV40 72 base pair repeat has a striking effect on gene expression both in SV40 and other chimeric recombinants. Nucl. Acids. Res. 9: 6047-6068.
67. Nakano, I., Maertens, G., Major, M. E., Vitvitski, L., Dubuisson, J., Fournillier, A., De Martynoff, G., Trepo, C., and Inchauspe, G. 1997. Immunization with plasmid DNA encoding hepatitis C virus envelope E2 antigenic domains induces antibodies whose immune reactivity is linked to the injection mode. J. Virol. 71: 7101-7109.
68. Pfarr, D. S., Rieser, L. A., Woyehik, R. P., Rottman, F. M., Rosenberg, M., and Reff, M. E. 1986. Differential effects of polyadenylation regions on gene expression in mammalian cells. DNA 5: 115-122.
69. Porter, K. R., Kochel, T. J., Wu, S. J., Raviprakash, K., Phillips, I., and Hayes, C. G. 1998. Protection efficacy of a dengue 2 DNA vaccine in mice and the effect of CpG immuno-stimulatory motifs on antibody responses. Arch. Virol. 143: 997-1003.
70. Putkonen, P., Quesada-Rolander, M., Leandersson, A.C., Schwartz, S., Thorstensson, R., Okuda, K., Wahren, B., and Hinkula, J. 1998. Immune responses but no protection against SHIV by gene-gun delivery of HIV-1 DNA followed by recombinant subunit protein boosts. Virology 250: 293-301.
71. Raz, E., Carson, D. A., Parker, S. E., Parr, T. B., Abai, A. M., Aichinger, G., Gromkowski, S. H., Singh, M., Lew, D., and Yankauckas, M. A. 1994. Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc. Natl. Acad. Sci. U.S.A. 91: 9519-9523.
72. Sasaki, S., Fukushima, J., Arai, H., Kusakabe, K. I., Hamajima, K., Ishii, N., Hirahara, F., Okuda, K., Kawamoto, S., Ruysschaert, J. M., Vandenbranden, M., Whahrew, B., and Okuda, K. 1997. Human immunodeficiency virus type-1 specific immune responses induced by DNA vaccination are greatly enhanced by mannan-coated diC14-amidine. Eur. J. Immunol. 27: 3121-3129
73. Sasaki, S., Sumino, K., Hamajima, K., Fushima, J., Ishii, N., Kawamoto, S., Mohri, H., Kensil, C. R., and Okuda, K. 1998. Induction of systemic and mucosal immune responses to human immunodeficiency virus type 1 by a DNA vaccine formulated with QS-21 saponin adjuvant via intramuscular and intranasal routes. J. Virol. 72: 4931-4939.
74. Sato, Y., Roman, M., Tighe, H., Lee, D., Corr, M., Nguyen, M. D., Silverman, G. J., Lotz, M., Carson, D. A., and Raz, E. 1996. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273: 352-354.
75. Schneider, J., Gilber, S. C., Blanchard, T. J., Hanke, T., Robson, K. J., Hannan, C. M., Becker, M., Sinden, R., Smith, G. L., and Hill, A. V. S. 1998. Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nat. Med. 4: 397-402.
76. Sedegah, M., Hedstrom, R., Hobart, P., and Hoffman, S. L. 1994. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc. Natl. Acad. Sci. U.S.A. 91: 9866-9870.
77. Sedegah, M., Jones, T. R., Kaur, M., Hedstrom, R., Hobart, P., Tine, J. A., and Hoffman, S. L. 1998. Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine. Proc. Natl. Acad. Sci. U.S.A. 95: 7648-7653.
78. Shiver, J. W., Perry, H. C., Davis, M. E., Freed, D. C., and Liu, M. A. 1995. Cytotoxic T lymphocytes and helper T cell responses following HIV polynucleotide vaccination. Ann. NY Acad. Sci. 772: 198-208.
79. Shiver, J. W., Ulmer, J. B., Donnelly, J. J., and Liu, M. A. 1996. Humoral and Cellular immunities elicited by DNA vaccines: application to the human immunodeficiency virus and influenza. Adv. Drug. Deliv. Rev. 21: 19-31.
80. Stevenson, F. K., Zhu, D., King, C. A., Ashworth, L. J., Kumar, S., and Hawkins, R. E. 1995. Idiotypic DNA vaccines against B cell lymphoma. Immunol. Rev. 145: 211-228.
81. Sutler, G. and Moss, B. 1992. Nonreplicating vaccinia vector efficiently expresses recombinant genes. Proc. Natl. Acad. Sci. U.S.A. 89: 10847-10851.
82. Syrengelas, A. D., Chen, T. T., and Levy, R. 1996. DNA immunization induces protective immunity against B cell lymphoma. Nat. Med. 2: 1038-1041.
83. Tascon, R. E., Colston, M. J., Ragno, S., Stavropoulos, E., Gregory, D., and Lowrie, D. B. 1996. Vaccination against tuberculosis by DNA injection. Nat. Med. 2: 888-892.
84. Thomson, S. A., Sherritt, M. A., Medveczky, J., Elliott, S. L., Moss, D. J., Fernando, G. J., Brown, L. E., and Suhrbier, A. 1998. Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination. J. Immunol. 160: 1717-1723.
85. Toda, S., Ishii, N., Okada, E., Kusakabe, K. I., Arai, H., Hamajima, K., Gorai, I., Nishioka, K., and Okuda, K. 1997. HIV-1 specific cell-mediated immune responses induced by DNA vaccination were enhanced by mannan-coated liposomes and inhibited by anti-interferon-gamma antibody. Immunology 92: 111-117.
86. Tokushige, K., Wakita, T., Pachuk, C., Moradpour, Weiner, D. B., Zurawski, V. R., Jr., and Wands, J. R. 1996. Expression and immune response to hepatitis C virus core DNA-based vaccine constructs. Hepatology 24: 14-20.
87. Ugen, K. E., Nyland, S. B., Boyer, J. D., Vidal, C., Lera, L., Rasheid, S., Chattergoon, M., Bagarazzi, M. L., Ciccarelli, R., Higgins, T., Baine, Y., Ginsberg, R., Macgregor, R. R., and Weiner, D. B. 1998. DNA vaccination with HIV-1 expressing constructs elicits immune responses in humans. Vaccine 16: 1818-1821.
88. Ulmer, J.B., Donnelly, J. J., Parker, S. E., Rhodes, G. H., Felgner, P. L., Dwarki, V. J., Gromkowski, S. H., Deck, R.R., Dewitt, C. M., Friedman, A., Hawe, L. A., Leander, K. R., Marninez, D., Perry, H. C., Shiver, J. W., Montgomery, D. L., and Liu, M. A. 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259: 1745-1749.
89. Valenzuela, P., Medina, A., Rutter, W. J., Ammerer, G., and Hall, B. D. 1982. Synthesis and assembly of hepatitis B virus surface antigen particles in yeast. Nature 298: 347-350.
90. Vitadello, M., Schiaffino, M. V., Picard, A., Searpa, M., and Schiaffino, S. 1994. Gene transfer in regenerating muscle. Hum. Gene Ther. 5: 11-18.
91. Wang, B., Boyer, J. D., Srikantan, V., Coney, L., Carrano, R., Phan, C., Merva, M., Dang, K., Agadjanyan, M., Gilbert, L., Ugen, K., Williams, V. W., and Weiner, D. B. 1993b. DNA inoculation induces neutralizing immune responses against human immunodeficiency virus type 1 in mice and non-human primates. DNA Cell Biol. 12: 799-805.
92. Wang, B., Boyer, J., Srikantan, V., Ugen, K., Gilbert, L., Phan, C., Dang, K., Merva, M., Agadjanyan, M. G., Newman, M., Carrano, R., McCallus, D., Corey, L., Williams, W. V., and Weiner, D. B. 1995. Induction of humoral and cellular immune responses to the human immunodeficiency type 1 virus in nonhuman primates. Virology 221: 102-112.
93. Wang, B., Ugen, K. E., Srikantin, V., Agadjanyan, M. G. Dang, K., Refaeli, Y., Sato, Al., Boyer, J., Williams, W. V., and Weiner, D. B. 1993a. Gene inoculation generates immune responses against human immunodeficiency virus type I. Proc. Natl. Acad. Sci. U.S.A. 90: 4156-4160.
94. Wang, R., Doolan, D. L., Charoenvit, Y., Hedstrom, R. C., Gardner, M. J., Hobart, P., Tine, J., Sedegah, M., Fallarme, V., Sacci, J. B., Jr., Kaur, M., Klinman, D. M., Hoffman, S. L., and Weiss, W. R. 1998a. Simultaneous induction of multiple antigen-specific cytotoxic T lymphocytes in nonhuman primates by immunization with a mixture of four Plasmodium falciparum DNA plasmids. Infect Immun. 66: 4193-4202.
95. Wang, R., Doolan, D. L., Le, T. P., Hedstrom, R. C., Coonan, K. M., Charoenvit, Y., Jones, T. R., Hobart, P., Margalith, M., Ng, J., Weiss, W. R., Sedegah, M., de Taisne, C. A., Noman, J., and Hoffman, S. L. 1998b. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science 282: 476-480.
96. Weinberg, A. and Merigan, T. C. 1988. Recombinant interleukin 2 as an adjuvant for vaccine-induced protection. Immunization of guinea pigs with herpes simplex virus subunit vaccines. J. Immunol. 140: 294-299.
97. Weiss, W. R., Ishii, K. J., Hedstrom, R. C., Sedegah, M., Ichino, M., Barnhart, K., Klinman, D. M., and Hoffman, S. L. 1998. A plasmid encoding murine granulocyte-macrophage colony stimulating factor increases protection conferred by a malaria DNA vaccine. J. Immunol. 161: 2325-2332.
98. Wild, J., Gruner, B., Metzqer, K., Kuhrober, A., Pudollek, H. P., Hauser, H., Schirmbeck, R., and Reimann, J. 1998. Polyvalent vaccination against hepatitis B surface and core antigen using a dicistronic expression plasmid. Vaccine 16: 353-360.
99. Williams, R. S., Johnston, S. A., Reidy, M., Devit, M. J., McElligott, S. G., and Sanford, J. C. 1991. Introduction of foreign genes into tissues of living mice by DNA-coated micro-projectiles. Proc. Natl. Acad. Sci. U.S.A. 88: 2726-2730.
100. Wolff, J. A., Malone, R. W., Williams, P., Chong, W., Aesadi, G., Jani, A., and Feigner, P. L. 1990. Direct gene transfer into mouse muscle in vivo. Science 247: 1465-1468.
101. Xiang, Z. Q., Spitalnik, S. L., Cheng, J., Erikson, J., Wojczyk, B., and Ertl, H. C. J. 1995. Immune responses to nucleic acid vaccines to rabies virus. Virology 209: 569-579.
102. Xin, K. Q., Hamajima, K., Sasaki, S., Honsho, A., Tsuji, T., Ishii, N., Cao, X. R., Lu, Y., Fukushima, J., Shapshak, P., Kawamoto, S., and Okuda, K. 1998. Intranasal administration of human immunodeficiency virus type-1 (HIV-1) DNA vaccine with interleukin-2 expression plasmid enhances cell-mediated immunity against HIV-1. Immunology 94: 438-444.
103. Yasutomi, Y., Robinson, H. L., Lu, S., Mustafa, F., Lekutis, C., Arthos, J., Mullins, J. I., Voss, G., Manson, K., Wyand M., and Letvin N. L. 1996. Simian immunodeficiency virus-specific cytotoxic T-lymphocyte induction through DNA vaccination of rhesus monkeys. J. Virol. 70: 678-681.